HIF-1α通过激活Cx43促进肺动脉平滑肌细胞的增殖和迁移

2021-10-29 刘少飞 MedSci原创

肺动脉平滑肌细胞的增殖是缺氧诱导的肺动脉高压(HPH)肺血管重塑的重要原因。HIF-1α作为上游调节因子促进Cx43的表达,HIF-1α/Cx43轴可调节HPH中肺动脉平滑肌细胞的增殖和迁移。

慢性缺氧性肺动脉高压(HPH)是一种不治之症,通常是慢性心力衰竭、慢性阻塞性肺疾病和睡眠呼吸暂停患者的并发症。 肺血管重构在HPH病理学中起重要作用,主要表现为肺动脉壁增厚和管腔狭窄。 肺动脉平滑肌细胞(PASMCs)的增殖和迁移是肺血管重塑的主要原因。 抑制PASMCs增殖和迁移有望成为PH治疗的主要途径。

连接蛋白 (Cxs) 是一种跨膜蛋白,可寡聚化在细胞膜上形成一个孔,称为半通道,并与小调节分子相互作用,如 3',5'-环磷酸腺苷 (cAMP)、5' 三磷酸腺苷 (ATP) )、钙 (Ca2+) 和肌醇 1,4,5-三磷酸 (IP3),可直接穿过细胞膜。在血管系统中,核心 Cxs 是 Cx37、Cx40 和 Cx43,这些基因的缺失会导致严重的心血管异常。

最近的研究表明,Cx43 在肺动脉高压 (PH) 中的作用已引起越来越多的关注。不幸的是,Cx43 在 VSMCs PH 功能中的生物学作用在很大程度上仍然未知。

在本研究中,通过用氯化钴 (CoCl2) 培养 PASMC 或将 SD 大鼠暴露于 10% O2 来建立缺氧模型,然后观察缺氧条件下增殖和迁移的变化。 此外,还探讨了 Cx43 对 CoCl2 治疗 PASMC 功能障碍的影响以及潜在机制。

研究设计:

该研究首先通过构建HPH大鼠模型,并发现在肺动脉中Cx43 和 p-Cx43显著上调。据报道,缺氧可调节不同细胞模型中 Cx43 的表达和通道活性。然而,目前没有可用的数据来说明 Cx43 通道在缺氧微环境中 PASMC 中的作用及其对细胞增殖和迁移的假定参与。该研究发现缺氧上调 Cx43 和 在 PASMC 中 Cx43 Ser 368 的磷酸化表达。

image

为了确定 Cx43 在 PASMC 增殖和迁移中的作用,我们通过使用 Cx43 靶向 shRNA 或 Gap27(一种 Cx37 和 Cx43 的特定 Cx 模拟肽阻滞剂)敲低其表达来操纵Cx43。

image

为了检测缺氧上调 Cx43 表达的分子机制,该研究接下来关注 HIF-1α,它是 HPH 的标志,并通过调节 PASMC 增殖和迁移促进血管重塑的进程。首先测试了缺氧是否 调节 PASMC 中 HIF-1α 的表达。

image

先前的研究表明,在暴露于慢性缺氧 (CH) 或用野百合碱 (MCT) 治疗的 Sprague-Dawley 大鼠中,升高的压力导致来自主动脉的培养细胞中 Cx43 蛋白表达的增加,并且肺中 Cx43 的表达增加。因此,为了进一步确定 HIF-1α 对 Cx43 调节的影响,该研究检查了不同浓度的 HIF-1α 抑制剂棘霉素对 PASMC 的影响,并发现棘霉素消除了对 Cx43 和 p-Cx43 的缺氧促进作用。

image

文献出处:

Han XJ, Zhang WF, Wang Q, Li M, Zhang CB, Yang ZJ, Tan RJ, Gan LJ, Zhang LL, Lan XM, Zhang FL, Hong T, Jiang LP. HIF-1α promotes the proliferation and migration of pulmonary arterial smooth muscle cells via activation of Cx43. J Cell Mol Med. 2021 Oct 26. doi: 10.1111/jcmm.17003. Epub ahead of print. PMID: 34698450.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1981302, encodeId=78fe1981302b2, content=<a href='/topic/show?id=c20f488e7cd' target=_blank style='color:#2F92EE;'>#平滑肌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48877, encryptionId=c20f488e7cd, topicName=平滑肌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Wed Jan 05 13:24:05 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641004, encodeId=457416410045b, content=<a href='/topic/show?id=7c99939e3fd' target=_blank style='color:#2F92EE;'>#迁移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93973, encryptionId=7c99939e3fd, topicName=迁移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37c22750496, createdName=ms8888626721583891, createdTime=Wed Dec 01 13:24:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691736, encodeId=e48f1691e367c, content=<a href='/topic/show?id=8ed9488e37e' target=_blank style='color:#2F92EE;'>#平滑肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48873, encryptionId=8ed9488e37e, topicName=平滑肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5d29283334, createdName=shijzhiewnjhch, createdTime=Thu Sep 15 20:24:05 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522161, encodeId=3b401522161bf, content=<a href='/topic/show?id=1b34881e59' target=_blank style='color:#2F92EE;'>#HIF-1α#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8817, encryptionId=1b34881e59, topicName=HIF-1α)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=847f11414102, createdName=changfy, createdTime=Sat Oct 30 06:24:05 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556056, encodeId=7a8a15560565d, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Sat Oct 30 06:24:05 CST 2021, time=2021-10-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1981302, encodeId=78fe1981302b2, content=<a href='/topic/show?id=c20f488e7cd' target=_blank style='color:#2F92EE;'>#平滑肌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48877, encryptionId=c20f488e7cd, topicName=平滑肌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Wed Jan 05 13:24:05 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641004, encodeId=457416410045b, content=<a href='/topic/show?id=7c99939e3fd' target=_blank style='color:#2F92EE;'>#迁移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93973, encryptionId=7c99939e3fd, topicName=迁移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37c22750496, createdName=ms8888626721583891, createdTime=Wed Dec 01 13:24:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691736, encodeId=e48f1691e367c, content=<a href='/topic/show?id=8ed9488e37e' target=_blank style='color:#2F92EE;'>#平滑肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48873, encryptionId=8ed9488e37e, topicName=平滑肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5d29283334, createdName=shijzhiewnjhch, createdTime=Thu Sep 15 20:24:05 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522161, encodeId=3b401522161bf, content=<a href='/topic/show?id=1b34881e59' target=_blank style='color:#2F92EE;'>#HIF-1α#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8817, encryptionId=1b34881e59, topicName=HIF-1α)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=847f11414102, createdName=changfy, createdTime=Sat Oct 30 06:24:05 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556056, encodeId=7a8a15560565d, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Sat Oct 30 06:24:05 CST 2021, time=2021-10-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1981302, encodeId=78fe1981302b2, content=<a href='/topic/show?id=c20f488e7cd' target=_blank style='color:#2F92EE;'>#平滑肌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48877, encryptionId=c20f488e7cd, topicName=平滑肌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Wed Jan 05 13:24:05 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641004, encodeId=457416410045b, content=<a href='/topic/show?id=7c99939e3fd' target=_blank style='color:#2F92EE;'>#迁移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93973, encryptionId=7c99939e3fd, topicName=迁移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37c22750496, createdName=ms8888626721583891, createdTime=Wed Dec 01 13:24:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691736, encodeId=e48f1691e367c, content=<a href='/topic/show?id=8ed9488e37e' target=_blank style='color:#2F92EE;'>#平滑肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48873, encryptionId=8ed9488e37e, topicName=平滑肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5d29283334, createdName=shijzhiewnjhch, createdTime=Thu Sep 15 20:24:05 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522161, encodeId=3b401522161bf, content=<a href='/topic/show?id=1b34881e59' target=_blank style='color:#2F92EE;'>#HIF-1α#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8817, encryptionId=1b34881e59, topicName=HIF-1α)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=847f11414102, createdName=changfy, createdTime=Sat Oct 30 06:24:05 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556056, encodeId=7a8a15560565d, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Sat Oct 30 06:24:05 CST 2021, time=2021-10-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1981302, encodeId=78fe1981302b2, content=<a href='/topic/show?id=c20f488e7cd' target=_blank style='color:#2F92EE;'>#平滑肌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48877, encryptionId=c20f488e7cd, topicName=平滑肌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Wed Jan 05 13:24:05 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641004, encodeId=457416410045b, content=<a href='/topic/show?id=7c99939e3fd' target=_blank style='color:#2F92EE;'>#迁移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93973, encryptionId=7c99939e3fd, topicName=迁移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37c22750496, createdName=ms8888626721583891, createdTime=Wed Dec 01 13:24:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691736, encodeId=e48f1691e367c, content=<a href='/topic/show?id=8ed9488e37e' target=_blank style='color:#2F92EE;'>#平滑肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48873, encryptionId=8ed9488e37e, topicName=平滑肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5d29283334, createdName=shijzhiewnjhch, createdTime=Thu Sep 15 20:24:05 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522161, encodeId=3b401522161bf, content=<a href='/topic/show?id=1b34881e59' target=_blank style='color:#2F92EE;'>#HIF-1α#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8817, encryptionId=1b34881e59, topicName=HIF-1α)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=847f11414102, createdName=changfy, createdTime=Sat Oct 30 06:24:05 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556056, encodeId=7a8a15560565d, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Sat Oct 30 06:24:05 CST 2021, time=2021-10-30, status=1, ipAttribution=)]
    2021-10-30 changfy
  5. [GetPortalCommentsPageByObjectIdResponse(id=1981302, encodeId=78fe1981302b2, content=<a href='/topic/show?id=c20f488e7cd' target=_blank style='color:#2F92EE;'>#平滑肌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48877, encryptionId=c20f488e7cd, topicName=平滑肌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Wed Jan 05 13:24:05 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641004, encodeId=457416410045b, content=<a href='/topic/show?id=7c99939e3fd' target=_blank style='color:#2F92EE;'>#迁移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93973, encryptionId=7c99939e3fd, topicName=迁移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37c22750496, createdName=ms8888626721583891, createdTime=Wed Dec 01 13:24:05 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691736, encodeId=e48f1691e367c, content=<a href='/topic/show?id=8ed9488e37e' target=_blank style='color:#2F92EE;'>#平滑肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48873, encryptionId=8ed9488e37e, topicName=平滑肌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5d29283334, createdName=shijzhiewnjhch, createdTime=Thu Sep 15 20:24:05 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522161, encodeId=3b401522161bf, content=<a href='/topic/show?id=1b34881e59' target=_blank style='color:#2F92EE;'>#HIF-1α#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8817, encryptionId=1b34881e59, topicName=HIF-1α)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=847f11414102, createdName=changfy, createdTime=Sat Oct 30 06:24:05 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556056, encodeId=7a8a15560565d, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Sat Oct 30 06:24:05 CST 2021, time=2021-10-30, status=1, ipAttribution=)]
    2021-10-30 wrj0126

相关资讯

Nat Commun:HIF-1α和HIF-2α在肾透明细胞癌中发挥相反的调节作用

2018年全球范围内新发肾癌病例超过40万例,而肾透明细胞癌(ccRCC)占所有肾癌的70–80%。在大多数ccRCC患者中均发生VHL(逢希伯-林道综合征,von Hippel-Lind

J Periodontol:健康和牙周疾病中龈沟液及唾液中HIF-1α, VEGF和TNF-α水平变化

低氧诱导因子1 alpha (HIF-1α)表达的出现是组织在低氧环境下的适应性反应,它可以通过表达血管内皮生长因子(VEGF)介导血管再生,并且可以由肿瘤坏死因子-alpha (TNF-α)诱导得来。这篇研究的目的是为了调查健康和牙周疾病个体的龈沟液(GCF)及唾液中HIF-1α, VEGF和TNF-α的表达水平变化。

Cell Death Differ:Arrb2促进HIF-1α降解调控胶质母细胞瘤的发生发展

缺氧是一种生理相关的生物应激类型,由于氧气供应和氧气需求之间的不平衡,许多实体瘤都存在着缺氧区域。

J Endod:Toll-like受体2/IL-10双敲小鼠内牙髓感染导致的炎症与颌骨骨髓炎相似

一般来讲,小鼠牙髓感染后会导致慢性不愈合的尖周损伤。令人惊奇的是,作者近日研究发现,Toll-like受体2(TLR2)/IL-10双敲(dKO)小鼠展现出急性但可治愈的骨髓炎样炎症反应。为此,这篇研究的目的是为了检测TLR2/IL-10 dKO小鼠牙髓感染引起的炎症变化以及探索缺氧诱导因子(HIF-1α)亚基和精氨酸酶1介导的尖周损伤愈合的潜在机制。

Cell Death Dis:ASC调节HIF-1α的稳定性诱导口腔鳞状细胞癌的转移

口腔鳞状细胞癌(OSCC)常发于口腔中的舌头、颊区域、嘴唇、牙龈和硬腭中,是最常见的头颈癌之一。OSCC的主要治疗方法是手术切除结合放疗或化疗进行治疗。然而该方法主要针对于原发性的肿瘤,OSCC的转移

Blood:输血可逆转镰状细胞病的异常血管生成

中心点:缓慢的RBC流动和血管堵塞触发了HIF-1α诱导的异常血管生长的促血管生成环境。在SCD小鼠中,输血可逆转新血管的生成,突出了BM血管系统的可塑性。摘要:镰状细胞病(SCD)是一种高发病率、高死亡率的单基因红细胞病。本文首次报道了SCD对骨髓(BM)血管生态位(对造血至关重要)的影响。研究人员在SCD小鼠中发现了一个无组织的、结构异常的BM血管网络,该BM腔的大部分都是高度弯曲的小动脉,以